Advisor Group Inc. increased its position in Cerner Co. (NASDAQ:CERN) by 1.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 71,675 shares of the company’s stock after purchasing an additional 1,220 shares during the quarter. Advisor Group Inc.’s holdings in Cerner were worth $4,829,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. grew its position in shares of Cerner by 2.2% during the 4th quarter. BlackRock Inc. now owns 19,519,304 shares of the company’s stock worth $1,315,406,000 after buying an additional 420,942 shares during the period. Capital International Investors increased its holdings in shares of Cerner by 0.3% during the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock worth $345,994,000 after acquiring an additional 12,178 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Cerner by 2.7% during the 4th quarter. Geode Capital Management LLC now owns 3,759,894 shares of the company’s stock worth $252,916,000 after acquiring an additional 98,444 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Cerner by 3.7% during the 4th quarter. American Century Companies Inc. now owns 3,204,461 shares of the company’s stock worth $215,949,000 after acquiring an additional 114,224 shares during the last quarter. Finally, Legal & General Group Plc increased its holdings in shares of Cerner by 1.8% during the 3rd quarter. Legal & General Group Plc now owns 1,477,451 shares of the company’s stock worth $105,371,000 after acquiring an additional 25,842 shares during the last quarter. Hedge funds and other institutional investors own 77.77% of the company’s stock.
Shares of Cerner Co. (NASDAQ:CERN) opened at $64.91 on Monday. The stock has a market capitalization of $21,590.00, a price-to-earnings ratio of 30.47, a PEG ratio of 1.91 and a beta of 0.93. Cerner Co. has a 1-year low of $54.49 and a 1-year high of $73.86. The company has a current ratio of 3.01, a quick ratio of 2.99 and a debt-to-equity ratio of 0.11.
In related news, Director William D. Zollars sold 4,100 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $62.16, for a total transaction of $254,856.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Michael R. Battaglioli sold 4,000 shares of the company’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $69.89, for a total value of $279,560.00. Following the sale, the vice president now owns 4,000 shares of the company’s stock, valued at $279,560. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 595,800 shares of company stock valued at $38,133,420. 13.11% of the stock is owned by corporate insiders.
A number of research analysts have commented on the company. Cantor Fitzgerald decreased their price objective on Cerner from $83.00 to $80.00 and set an “overweight” rating on the stock in a report on Wednesday, February 7th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Cerner in a report on Thursday, November 30th. Citigroup assumed coverage on Cerner in a report on Thursday, January 4th. They issued a “neutral” rating on the stock. BidaskClub lowered Cerner from a “buy” rating to a “hold” rating in a report on Friday, December 22nd. Finally, Zacks Investment Research raised Cerner from a “sell” rating to a “hold” rating in a report on Tuesday, December 26th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $67.66.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.